Qualigen Therapeutics logo

Qualigen Therapeutics Share Price (NASDAQ: QLGN)

$1.76

Last updated on

Check the interactive Qualigen Therapeutics Stock chart to analyse performance

Qualigen Therapeutics stock performance

as on August 30, 2025 at 1:26 am IST

  • Today's Low:$1.75
    Today's High:$1.85

    Day's Volatility :5.41%

  • 52 Weeks Low:$1.61
    52 Weeks High:$10.45

    52 Weeks Volatility :84.59%

Qualigen Therapeutics Stock Returns

PeriodQualigen Therapeutics IncIndex (Russel 2000)
3 Months
-55.1%
0.0%
6 Months
-43.23%
0.0%
1 Year
-81.14%
0.0%
3 Years
-99.07%
-4.1%

Qualigen Therapeutics Inc Key Stats

Check Qualigen Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.76
Open
$1.85
Today's High
$1.85
Today's Low
$1.75
Market Capitalization
$3.1M
Today's Volume
$22.8K
52 Week High
$10.45
52 Week Low
$1.61
Revenue TTM
$5.0M
EBITDA
$-6.9M
Earnings Per Share (EPS)
$6.11
PE Ratio
0.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-841.66%

Stock Returns calculator for Qualigen Therapeutics Stock including INR - Dollar returns

The Qualigen Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Qualigen Therapeutics investment value today

Current value as on today

₹24,148

Returns

₹75,852

(-75.85%)

Returns from Qualigen Therapeutics Stock

₹81,136 (-81.14%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Qualigen Therapeutics Stock

-89%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Qualigen Therapeutics Stock from India on INDmoney has decreased by -89% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Qualigen Therapeutics Inc

  • Name

    Holdings %

  • FNY Investment Advisers, LLC

    0.46%

  • Tower Research Capital LLC

    0.07%

  • BlackRock Inc

    0.03%

  • HARBOUR INVESTMENTS, INC.

    0.02%

Analyst Recommendation on Qualigen Therapeutics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Qualigen Therapeutics(by analysts ranked 0 to 5 stars)

Qualigen Therapeutics Share Price Target

What analysts predicted

Upside of 184.09%

Target:

$5.00

Current:

$1.76

Qualigen Therapeutics share price target is $5.00, a slight Upside of 184.09% compared to current price of $1.76 as per analysts' prediction.

Qualigen Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, QLGN stock has moved down by -20.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 7.94M → 2.23M (in $), with an average decrease of 71.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -855.82K → -1.68M (in $), with an average decrease of 96.9% per quarter
  • QLGN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 151.1%
  • QLGN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 215.1%
  • Price to Sales

    ForQLGN every $1 of sales, investors are willing to pay $1.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Qualigen Therapeutics Technicals Summary

Sell

Neutral

Buy

Qualigen Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Qualigen Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Qualigen Therapeutics Inc logo
-18.89%
-43.23%
-81.14%
-99.07%
-99.93%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was founded in 1996 and is based in Carlsbad, California.
Organization
Qualigen Therapeutics
Employees
0
CEO
Mr. Kevin A. Richardson II
Industry
Health Technology

Key Management of Qualigen Therapeutics Inc

NameTitle
Mr. Kevin A. Richardson II
Interim CEO, Interim CFO, Chief Accounting Officer & Chairman of the Board
Mr. Robert W. Campbell Becher
President & Director
Mr. Michael S. Poirier
Chief Operating Officer
Mr. Christopher L. Lotz
VP of Finance & Corporate Secretary

Important FAQs about investing in QLGN Stock from India :

What is Qualigen Therapeutics share price today?

Qualigen Therapeutics share price today is $1.76 as on at the close of the market. Qualigen Therapeutics share today touched a day high of $1.85 and a low of $1.75.

What is the 52 week high and 52 week low for Qualigen Therapeutics share?

Qualigen Therapeutics share touched a 52 week high of $10.45 and a 52 week low of $1.61. Qualigen Therapeutics stock price today i.e. is closed at $1.76, lower by 83.16% versus the 52 week high.

How to invest in Qualigen Therapeutics Stock (QLGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Qualigen Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Qualigen Therapeutics Shares that will get you 0.8523 shares as per Qualigen Therapeutics share price of $1.76 per share as on August 30, 2025 at 1:26 am IST.

What is the minimum amount required to buy Qualigen Therapeutics Stock (QLGN) from India?

Indian investors can start investing in Qualigen Therapeutics (QLGN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Qualigen Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Qualigen Therapeutics share’s latest price of $1.76 as on August 30, 2025 at 1:26 am IST, you will get 5.6818 shares of Qualigen Therapeutics. Learn more about fractional shares .

What are the returns that Qualigen Therapeutics has given to Indian investors in the last 5 years?

Qualigen Therapeutics stock has given -99.93% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?